Navigation Links
New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia
Date:12/17/2007

es. For further details of these and other risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 1A, "Risk Factors" in the company's third quarter 2007 10-Q.

References

(1) World Health Organization. Available online at: http://www.who.int/mental_health/management/schizophrenia/en/. Accessed on October 2, 2007.

(2) National Institute of Mental Health. Available online at: http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml

(3) World Health Organization. WHO European Ministry Conference on Mental Health. Available online at: http://www.euro.who.int/document/MNH/emnhqa.pdf. Accessed on October 2, 2007.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...CAMBRIDGE, Mass., Nov. 19 Ligon Di...le microarray technology to find drugs against hig...d $1M in seed financing led by incTANK Ventures. T...itial discovery campaign that will screen over 100...estment, incTANK Ventures General Partner Christia...
(Date:11/19/2009)... Part of International Internet Week of Action ,...swire/ -- The U.S. Food and Drug Administration to...al effort, called the International Internet Week ... involving medical products. ,, (Logo: http://..., During the effort, the FDA,s Office of Crimina...
(Date:11/19/2009)...WPORT NEWS, Va., Nov. 19 Breast-Sp...I/MBI) has been recognized and endorsed by two hig...reast cancer: The Society of Breast Imaging (SBI) ...es published articles supporting the further appli... the early detection of breast cancer. ,, "Thes...
Breaking Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Custom Spine Receives 510k Clearance of Regent ACP 6014 1Custom Spine Receives 510k Clearance of Regent ACP 6014 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 1Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 2Bayer Consumer Care Launches Citracal 28R 29 Calcium Plus Heart Health First Ever Leading Calcium Supplement to Help Support Bone AND Heart Health 6011 3Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 1Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 2Competitive Technologies Selects RF 7CBinder as Public Relations Agency of Record 6008 3
...land, January 26 Debiopharm Group,(Debiopharm), a...hat focuses,on serious medical conditions and part...on of its first patient in a phase IIb clinical st...inhibitor with a potent anti-hepatitis C,(HCV) eff...trolled,parallel-group study will investigate the ...
...2nd Generation Oxazolidinone Enrolls in Four Month...c. today announced the completion of enrollment in...al testing the oral dosage form of torezolid (also...n and skin structure infections (cSSSI). The tria... United States, examined the efficacy and safety o...
Other Medicine Technology:Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2
(Date:11/21/2009)...es Key Provisions of Legislation, Continues Push f...ES, Ill., Nov. 21 Wit...ndmark Affordable Health Care for America Act (H.R...egislation forward, Congress has taken decisive st... Today, AARP hosted an educational forum to discu...
(Date:11/21/2009).... Hall, president and chief executive officer of t...the following statement regarding the inclusion of... annual wellness for Medicare beneficiaries in &qu...quot; that was introduced last night: , ...009 -- Eric J. Hall, president and chief executive...
(Date:11/20/2009)... The American Academy ...h care reform legislation released this week to co...ce individual coverage mandate. The actuaries said...nimize adverse selection stemming from more restri...l. ,, "The individual mandate language should b...
(Date:11/20/2009)...ewswire-USNewswire/ -- The American Dental Associa...nistration (FDA) to establish appropriate classifi...ng concern about the safety of whitening products ... professional consultation or examination by a den... chemically based tooth whitening or bleaching age...
(Date:11/20/2009)...0 SIRIUS XM Radio (Nas...t Doctor Radio Reports: What Every Women Needs ...ted by veteran journalist Perri Peltz. ,, (Log...YTU044LOGO ) ,, Doctor Radio Reports: What E...r November 21 live at 10:00 am ET on Doctor Rad...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...nstead of traditional immune globulin injection , ...eating the liver disease hepatitis A with the hepa...h the more traditional injection of immune globuli...w recommends the vaccine as the preferred treatmen...
...18 Edward Clarke of Lohengrin,Group announced tod...tnership with Global Medical Insurance, to offer a...rea. This partnership allows Lohengrin Group to o...raveling abroad. Health,insurance can be difficult...
...Conseco, Inc. (NYSE:,CNO) will report results for ...on October 31, 2007. The company will host a confe...n Daylight Time on November 1, 2007. The web cast...ould go to the website at least 15,minutes before ...
... Med Technologies(R),Inc. (OTC Bulletin Board: GLO... technology company, announced today that its Wynd...mitted its ElDorado Donor(TM),software for a 510(k... ElDorado Donor is intended as a comprehensive bl...
...AWAY, N.J. Dr. Wise Young, the Richard H. Shindel...and founding director of Rutgers W.M. Keck Center ...elvyn H. Motolinsky Research Foundations 2007 Dist...Academic Building at University of Medicine and De...
... heightened activity of neurotransmitter dopamine ...Researchers have identified molecular mechanisms i...ess vulnerable to the stress caused by difficult s...t-traumatic stress disorder suffered by troops in ...
Other Medicine News:Health News:Hepatitis A Vaccine Best Bet to Treat Virus 2Health News:Hepatitis A Vaccine Best Bet to Treat Virus 3Health News:Lohengrin Group Announces Bold New Product Line 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 3Health News:Spinal cord injury expert to be honored by research foundation 2Health News:Vulnerability to Stress Linked to Brain Molecule 2Health News:Vulnerability to Stress Linked to Brain Molecule 3
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: